Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1885 1
1893 1
1894 1
1901 1
1906 1
1907 1
1913 1
1915 1
1916 3
1917 1
1920 1
1921 1
1924 1
1944 1
1945 1
1948 5
1950 2
1952 1
1953 1
1954 4
1956 2
1957 3
1958 2
1959 2
1960 2
1962 1
1963 4
1964 2
1965 3
1966 2
1967 8
1968 8
1969 3
1970 8
1971 8
1972 4
1973 13
1974 8
1975 8
1976 4
1977 5
1978 8
1979 3
1980 8
1981 4
1982 9
1983 7
1984 9
1985 6
1986 5
1987 5
1988 16
1989 8
1990 9
1991 14
1992 19
1993 14
1994 12
1995 13
1996 23
1997 21
1998 25
1999 15
2000 27
2001 21
2002 28
2003 23
2004 36
2005 44
2006 64
2007 53
2008 45
2009 53
2010 54
2011 52
2012 39
2013 76
2014 65
2015 64
2016 75
2017 67
2018 84
2019 75
2020 74
2021 71
2022 80
2023 71
2024 76

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,655 results

Results by year

Filters applied: . Clear all
Page 1
What is value in health care?
Porter ME. Porter ME. N Engl J Med. 2010 Dec 23;363(26):2477-81. doi: 10.1056/NEJMp1011024. Epub 2010 Dec 8. N Engl J Med. 2010. PMID: 21142528 No abstract available.
Oral Psoriasis Therapies.
James J, Otto T, Gao J, Porter ML. James J, et al. Among authors: porter ml. Dermatol Clin. 2024 Jul;42(3):357-363. doi: 10.1016/j.det.2024.02.013. Epub 2024 Apr 4. Dermatol Clin. 2024. PMID: 38796267 Review.
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study.
Kirby JS, Okun MM, Alavi A, Bechara FG, Zouboulis CC, Brown K, Santos LL, Wang A, Bibeau KB, Kimball AB, Porter ML. Kirby JS, et al. Among authors: porter ml. J Am Acad Dermatol. 2024 Mar;90(3):521-529. doi: 10.1016/j.jaad.2023.10.034. Epub 2023 Oct 21. J Am Acad Dermatol. 2024. PMID: 37871805 Free article. Clinical Trial.
Brepocitinib, Zimlovisertib, and Ropsacitinib in Hidradenitis Suppurativa.
Kimball AB, Peeva E, Forman S, Moiin A, Khattri S, Porter ML, Mangold AR, Ghosh P, Banfield C, Oemar B. Kimball AB, et al. Among authors: porter ml. NEJM Evid. 2024 Mar;3(3):EVIDoa2300155. doi: 10.1056/EVIDoa2300155. Epub 2024 Feb 9. NEJM Evid. 2024. PMID: 38335032 Clinical Trial.
Williams syndrome.
Riby DM, Porter MA. Riby DM, et al. Among authors: porter ma. Adv Child Dev Behav. 2010;39:163-209. doi: 10.1016/b978-0-12-374748-8.00005-6. Adv Child Dev Behav. 2010. PMID: 21189808 Review. No abstract available.
Colour vision in stomatopod crustaceans.
Cronin TW, Porter ML, Bok MJ, Caldwell RL, Marshall J. Cronin TW, et al. Among authors: porter ml. Philos Trans R Soc Lond B Biol Sci. 2022 Oct 24;377(1862):20210278. doi: 10.1098/rstb.2021.0278. Epub 2022 Sep 5. Philos Trans R Soc Lond B Biol Sci. 2022. PMID: 36058241 Free PMC article. Review.
Biologic Treatment for Hidradenitis Suppurativa.
Flood KS, Porter ML, Kimball AB. Flood KS, et al. Among authors: porter ml. Am J Clin Dermatol. 2019 Oct;20(5):625-638. doi: 10.1007/s40257-019-00439-5. Am J Clin Dermatol. 2019. PMID: 31140067 Review.
The next critical role of orthopedic registries.
Malchau H, Graves SE, Porter M, Harris WH, Troelsen A. Malchau H, et al. Among authors: porter m. Acta Orthop. 2015 Feb;86(1):3-4. doi: 10.3109/17453674.2014.1002184. Epub 2015 Jan 13. Acta Orthop. 2015. PMID: 25583041 Free PMC article. No abstract available.
Individuals difference in developmental disorders.
Porter M, Campbell L. Porter M, et al. Res Dev Disabil. 2021 Jan;108:103814. doi: 10.1016/j.ridd.2020.103814. Epub 2020 Nov 20. Res Dev Disabil. 2021. PMID: 33227541 No abstract available.
1,655 results